title: Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
authors.forename: Martin
authors.initials: M
authors.lastname: Fassnacht
authors.forename: Eric
authors.initials: E
authors.lastname: Baudin
authors.forename: Gary
authors.initials: G
authors.lastname: Hammer
authors.forename: Harm
authors.initials: H
authors.lastname: Haak
authors.forename: Sophie
authors.initials: S
authors.lastname: Leboulleux
authors.forename: Britt
authors.initials: B
authors.lastname: Skogseid
authors.forename: Bruno
authors.initials: B
authors.lastname: Allolio
authors.forename: Massimo
authors.initials: M
authors.lastname: Terzolo
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018268:Adrenocortical Carcinoma / Q000188:drug therapy* / Q000601:surgery; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008939:Mitotane / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane